Latest news

AstraZeneca buys back its own startup for a new take on weight loss

AstraZeneca buys back its own startup for a new take on weight loss

Eduardo Longoria
Daily Snap - 7. November 2025

Daily Snap - 7. November 2025

Joachim Eeckhout
Axsome acquires AstraZeneca ́s epilepsy drug and runs with it

Axsome acquires AstraZeneca ́s epilepsy drug and runs with it

Joachim Eeckhout
Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Evommune soars past IPO slowdown with $150M debut amid federal shutdown

Joachim Eeckhout
Daily Snap - 6. November 2025

Daily Snap - 6. November 2025

Joachim Eeckhout
Merck (MSD) accelerates with a $700M boost for its cancer ADC drug

Merck (MSD) accelerates with a $700M boost for its cancer ADC drug

Joachim Eeckhout
Braveheart Bio loads up with $185M to challenge BMS’ heart drug with bold new contender

Braveheart Bio loads up with $185M to challenge BMS’ heart drug with bold new contender

Joachim Eeckhout
Roche supports AI-powered brain drug breakthrough with $55M

Roche supports AI-powered brain drug breakthrough with $55M

Joachim Eeckhout
FDA U-turn stalls promising Huntington's gene therapy from uniQure

FDA U-turn stalls promising Huntington's gene therapy from uniQure

Joachim Eeckhout
Daily Snap - 4. November 2025

Daily Snap - 4. November 2025

Joachim Eeckhout
Daily Snap - 3. November 2025

Daily Snap - 3. November 2025

Joachim Eeckhout
Corporate VCs fill biotech funding gap amid venture slowdown

Corporate VCs fill biotech funding gap amid venture slowdown

Joachim Eeckhout
FirstBack
4567891011
Next Last